Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 1
1988 1
1989 2
1995 1
2005 1
2006 1
2008 2
2009 1
2010 4
2011 3
2012 6
2013 4
2015 1
2016 1
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

27 results
Results by year
Filters applied: . Clear all
Page 1
Bioabsorbable Intracoronary Matrix for Prevention of Ventricular Remodeling After Myocardial Infarction.
Rao SV, Zeymer U, Douglas PS, Al-Khalidi H, White JA, Liu J, Levy H, Guetta V, Gibson CM, Tanguay JF, Vermeersch P, Roncalli J, Kasprzak JD, Henry TD, Frey N, Kracoff O, Traverse JH, Chew DP, Lopez-Sendon J, Heyrman R, Krucoff MW. Rao SV, et al. Among authors: heyrman r. J Am Coll Cardiol. 2016 Aug 16;68(7):715-23. doi: 10.1016/j.jacc.2016.05.053. J Am Coll Cardiol. 2016. PMID: 27515331 Free article. Clinical Trial.
The TRINITY Study: distribution of systolic blood pressure reductions.
Sugimoto DH, Chrysant SG, Melino M, Lee J, Fernandez V, Heyrman R. Sugimoto DH, et al. Among authors: heyrman r. Integr Blood Press Control. 2013 Jul 12;6:89-99. doi: 10.2147/IBPC.S45450. Print 2013. Integr Blood Press Control. 2013. PMID: 23901293 Free PMC article.
Pathogenesis of dialysis-induced hypoxemia: a short overview.
De Broe ME, Heyrman RM, De Backer WA, Verpooten GA, Vermeire PA. De Broe ME, et al. Among authors: heyrman rm. Kidney Int Suppl. 1988 Mar;24:S57-61. Kidney Int Suppl. 1988. PMID: 3129613 Review. No abstract available.
A double-blind, dose-response study of the efficacy and safety of olmesartan medoxomil in children and adolescents with hypertension.
Hazan L, Hernández Rodriguez OA, Bhorat AE, Miyazaki K, Tao B, Heyrman R; Assessment of Efficacy and Safety of Olmesartan in Pediatric Hypertension Study Group. Hazan L, et al. Among authors: heyrman r. Hypertension. 2010 Jun;55(6):1323-30. doi: 10.1161/HYPERTENSIONAHA.109.147702. Epub 2010 Apr 12. Hypertension. 2010. PMID: 20385971 Clinical Trial.
27 results